SGHT · Sight Sciences, Inc. · Executive Compensation
$10.08
+0.32 (+3.28%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$555.51M
Shares
55.58M
Volume · Nov 6
576.41K
Avg daily vol (3M)
300.98K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Paul Badawi | President and Chief Executive Officer | $2,005,608 |
| Alison Bauerlein | Chief Operating Officer | $1,626,754 |
| Matthew Link | Chief Commercial Officer | $1,216,918 |
| Jeremy Hayden | Chief Legal Officer | $974,254 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Paul Badawi | President and Chief Executive Officer | $3,022,179 |
| Alison Bauerlein | Chief Operating Officer | $2,238,543 |
| Jeremy Hayden | Chief Legal Officer | $1,479,652 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Matthew Link | Chief Commercial Officer | $2,357,650 |
| Alison Bauerlein | Chief Financial Officer | $1,848,183 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul Badawi | President and Chief Executive Officer | $5,749,624 |
| Jesse Selnick | Chief Financial Officer | $1,960,539 |
| Sam Park | Chief Operating Officer | $1,857,302 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Paul Badawi | President and Chief Executive Officer | $8,580,408 |
| Jesse Selnick | Chief Financial Officer | $3,762,695 |
| Sam Park | Chief Operating Officer | $1,353,250 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Sam Park | Chief Operating Officer | $588,360 |
| Paul Badawi | President and Chief Executive Officer | $496,710 |
| Jesse Selnick | Chief Financial Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kashif Rashid | Chief Legal Officer and Corporate Secretary | Appointed | 2026-08-10 |
| Erica Rogers | Class I director | Resigned | 2025-11-06 |
| Brenda Becker | Class I director | Resigned | 2025-11-06 |
| James Rodberg | Chief Financial Officer and Treasurer | Appointed | 2025-11-06 |
| Alison Bauerlein | Chief Operating Officer | Appointed | 2025-11-06 |
| Matthew Link | Chief Commercial Officer | Resigned | 2025-08-27 |
| Gerhard F. Burbach | Director | Appointed | 2025-06-05 |
| Gerhard F. Burbach | Class II director | Appointed | 2025-04-22 |
| Sam Park | Chief Operating Officer | Retired | 2024-11-07 |
| Matthew Link | Chief Commercial Officer | Appointed | 2023-09-11 |
| Jim Rodberg | interim Chief Financial Officer, interim Treasurer, Principal Financial Officer or Principal Accounting Officer | Resigned | 2023-04-03 |
| Alison Bauerlein | Chief Financial Officer and Treasurer | Appointed | 2023-04-03 |
| Tamara R. Fountain, M.D. | member of the Audit Committee | Appointed | 2023-01-09 |
| Mack Hicks | Class II director | Resigned | 2023-01-09 |
| Jim Rodberg | Interim Chief Financial Officer and Treasurer | Appointed | 2023-01-09 |
| Jesse Selnick | Chief Financial Officer and Treasurer | Resigned | 2023-01-09 |
| Tamara Fountain, M.D. | Class III director | Appointed | 2022-07-20 |
Leadership
- Paul Badawi CEO, Board Member
- James Rodberg CFO
- Jim Rodberg CFO
- Alison Bauerlein COO
- David Badawi CTO, Board Member
- Kashif Rashid General Counsel
- Catherine Mazzacco Board Member
- Donald Zurbay Board Member
- Gerhard Burbach Board Member
- Staffan Encrantz Board Member
- Tamara Fountain Board Member
- Tamara Fountain, M.D. Board Member
- Tamara R. Fountain Board Member
- Tamara R. Fountain, M.D. Board Member
Key facts
CIK
1531177
CUSIP
82657M105
13F (30d)
50 filings
38 filers
Visit website
Investor relations